Atlas Trials

Three Months of Weekly Rifapentine and Isoniazid for M. Tuberculosis Infection

Clinical trial NCT00023452 · COMPLETED

Trial details

NCT number
NCT00023452
Sponsor
Centers for Disease Control and Prevention
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Tuberculosis
Start date
2001-06-01
Primary completion
2010-10-01
Enrollment
8053

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.